Harvard Bioscience, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of HBIO for the last quarter is 28.15 M USD, and it's 11.00% higher compared to the previous quarter. The net income of Q4 23 is -1.82 M USD.